Top Percentage Gainers and Losers as of 2pm 5/10/11 (FONR, CKXE, TRAK, CPE, SREV, FFHL, MED, FOSL, BMTI, HEAT, PANL, MOBI, MNKD, VRML, USAT, ETM)

Best 1) Fonar FONR: Trading up 27.3% from yesterday's close to $2.77. Fonar reported a 15% increase in revenue to $8.7 million for the third quarter. Net income came in at $0.20 per share versus $7.5 million for the same period last year. Shares set a new 52-week high of $3.20 earlier in the session. 2) CKX CKXE: Trading up 22.7% from yesterday's close to $5.46. CKX is set to be acquired by Apollo Global Management LLC for $5.50 per share in cash. The deal is valued at $509 million. 3) Dealer Track Holdings TRAK: Trading up 20.4% from yesterday's close to $25.65. Dealer Track reported Q1 earnings of $0.59 per share versus a loss of $0.06 per share for the same period last year. Adjusted net income came in at $0.18 per share versus estimates of $0.11 per share. Shares set a new 52-week high of $26.46 earlier in the session. 4) Callon Petroleum CPE: Trading up 19.7% from yesterday's close to $7.40. Callon reported Q1 earnings of $0.12 per share versus estimates of $0.03 per share. Revenue came in at $25.4 million versus estimates of $24 million. 5) ServiceSource International SREV: Trading up 18.5% from yesterday's close to $17.70. ServiceSource reported record Q1 revenue of $46.1 million, which is 43% higher than the same period last year. Q1 revenue came in at $46.1 million versus revenue of $32.2 million for the same period last year. Other Notable Gainers Fuwei Films FFHL: Trading up 13.4% from yesterday's close to $4.15. Fuwei Films reported Q1 earnings of $0.28 per share versus earnings of $0.003 (RMB 0.02) for the same period last year. MEDIFAST MED: Trading up 14.6% from yesterday's close to $23.32. MEDIFAST reported Q1 earnings of $0.44 per share versus estimates of $0.41 per share. Revenue came in at $74.3 million versus estimates of $73.9 million. Fossil FOSL: Trading up 12.4% from yesterday's close to $105.65. Fossil reported earnings of $0.86 per share versus estimates of $0.66 per share. The company was raised from Hold to Buy at S&P Equity Research. Worst 1) BioMimetic Therapeutics BMTI: Trading down 35.2% from yesterday's close to $8.68. Augment, BioMimetic's bone graft product is to be the subject of a critical regulatory meeting. On Thursday, the U.S. Food and Drug Administration is to decide whether or not to recommend the approval of Augment. BioMimetic posted a loss of a $0.28 per share versus estimates of a $0.35 loss. 2) SmartHeat HEAT: Trading down 26.7% from yesterday's close to $2.31. SmartHeat posted a Q1 loss of $0.10 per share versus a loss of $0.05 for the same period last year. Sales came in 16% lower from a year ago at $7.89 million. 3) Universal Display PANL: Trading down 18.3% from yesterday's close to $46.25. Universal Display reported a Q1 loss of $0.08 per share versus estimates of a $0.03 loss. 4) Sky-mobi MOBI: Trading down 15.4% from yesterday's close to $11.28. Sky-mobi reported Q4 earnings of $0.01 versus estimates of $0.04. Sales came in at $27.1 million versus estimates of $24.85 million. 5) MannKind MNKD: Trading down 14.1% from yesterday's close to $3.77. Numerous reports regarding Mannkind's dwindling cash balance have been circulating today. Other Notable Losers Vermillion VRML: Trading down 10.9% from yesterday's close to $3.51. Vermillion reported 1Q revenue of $431,000 versus $73,000 for the same period last year. USA Technologies USAT: Trading down 11% from yesterday's close to $2.26. USA Technologies reported Q3 sales of $5.5 million – a 50% increase for the same period last year. The company reported a loss of $0.11 per share versus a loss of $0.10 for the same period last year. Entercom Communications ETM: Trading down 11.4% from yesterday's close to $9.04. Entercom was cut from Buy to Hold by Gilford Securities.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsShort IdeasUpgradesSmall Cap AnalysisTechnicalsIntraday UpdateMarketsMoversTrading IdeasApollo Global Management LLCAugmentgilford securitiesS&P Equity ResearchU.S. Food and Drug Administration
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!